Literature DB >> 3357875

Effect of four-day treatment with carbamazepine at different dose levels on microsomal enzyme induction, drug metabolism and drug toxicity.

L Regnaud1, G Sirois, S Chakrabarti.   

Abstract

The effect of intraperitoneal injections of 0, 30, 60 and 100 mg/kg of carbamazepine (CBZ), twice a day for 4 days, was studied in 4 groups of 6 male Sprague-Dawley rats per group to evaluate its hepatic enzymatic induction, toxicity and metabolism. Rats were sacrificed on the fifth day and the urines of the last 24 hours were collected. While the activities of hepatic microsomal aminopyrine N-demethylase and epoxide hydratase tended to increase with the dose of CBZ, the cytochrome P-450 content and the activity of aniline hydroxylase however reached a maximum at 60 mg/kg. The percentage of the administered daily dose of CBZ excreted as unchanged CBZ in the urine increased considerably with the dose, while that of metabolites such as carbamazepine-10,11-epoxide (CBZ-E), trans-10,11-dihydrodihydroxycarbamazepine (TDC), and thioethers (T) did not markedly change. These data not only corroborate a maximum in enzyme induction but also suggest a saturation of the induced hepatic enzymes. Urinary T and TDC, representing more than 50% and less than 10%, respectively of the total amount recovered, tend to demonstrate that the glutathione conjugation with the intermediates of CBZ leading to the formation of higher mercapturates could be more important than the epoxide-diol pathway for the metabolism of CBZ under conditions of repeated dosing.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3357875     DOI: 10.1111/j.1600-0773.1988.tb01834.x

Source DB:  PubMed          Journal:  Pharmacol Toxicol        ISSN: 0901-9928


  4 in total

1.  Pharmacokinetic interaction between carbamazepine and neuroleptics after combined prolonged treatment in rats.

Authors:  W Daniel; L Janczar; L Danek; W Legrum; K J Netter
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-05       Impact factor: 3.000

2.  Dose-dependent pharmacokinetics of carbamazepine in rats: determination of the formation clearance of carbamazepine-10,11-epoxide.

Authors:  R P Remmel; M W Sinz; J C Cloyd
Journal:  Pharm Res       Date:  1990-05       Impact factor: 4.200

Review 3.  Fulminant hepatic failure associated with status epilepticus in children: three cases and a review of potential mechanisms.

Authors:  M K Decell; J B Gordon; K Silver; K Meagher-Villemure
Journal:  Intensive Care Med       Date:  1994-05       Impact factor: 17.440

4.  Lymphocyte microsomal epoxide hydrolase in patients on carbamazepine therapy.

Authors:  M Pirmohamed; R Allott; V J Green; N R Kitteringham; D Chadwick; B K Park
Journal:  Br J Clin Pharmacol       Date:  1994-06       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.